OSTEOGENESIS IMPERFECTA TYPE III

Clinical trials for OSTEOGENESIS IMPERFECTA TYPE III explained in plain language.

Never miss a new study

Get alerted when new OSTEOGENESIS IMPERFECTA TYPE III trials appear

Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA TYPE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for growing stronger bones: stem cell trial for fragile children

Disease control Not yet recruiting

This early-stage study is testing whether infusions of donor stem cells are safe and might help children with a severe form of brittle bone disease (osteogenesis imperfecta type 3). Researchers will give 12 children, aged 3 to 10, six stem cell infusions over two years to see if …

Matched conditions: OSTEOGENESIS IMPERFECTA TYPE III

Phase: PHASE1, PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

OSTEOGENESIS IMPERFECTA TYPE III

Get alerted when new OSTEOGENESIS IMPERFECTA TYPE III trials appear

New hope for growing stronger bones: stem cell trial for fragile children